These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1618218)

  • 1. Differences in the antiischaemic effects of molsidomine and isosorbide dinitrate.
    Jost S
    Eur Heart J; 1992 May; 13(5):720. PubMed ID: 1618218
    [No Abstract]   [Full Text] [Related]  

  • 2. [Molsidomine and isosorbide dinitrate:/their comparative effectiveness in patients with exertion-induced stenocardia].
    Martsevich SIu; Metelitsa VI
    Kardiologiia; 1988 Jul; 28(7):68-70. PubMed ID: 3062225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effectiveness and duration of effect of molsidomine and isosorbide dinitrate in peripheral circulation].
    König FK; Grewe R; Wörz K
    Fortschr Med; 1985 Oct; 103(38):903-6. PubMed ID: 3908257
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of the hemodynamic responses to molsidomine and isosorbide dinitrate in congestive heart failure.
    Unger P; Vachiery JL; de Cannière D; Staroukine M; Berkenboom G
    Am Heart J; 1994 Sep; 128(3):557-63. PubMed ID: 8074020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical comparison of antiischemic efficacy of isosorbide dinitrate and molsidomine.
    Lehmann G; Reiniger G; Beyerle A; Schömig A
    J Cardiovasc Pharmacol; 1998 Jan; 31(1):25-30. PubMed ID: 9456273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meeting highlights: nitric oxide donors.
    Ferguson JJ
    Circulation; 1994 Jul; 90(1):4. PubMed ID: 8026024
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparative hemodynamic studies with molsidomine and isosorbide dinitrate after aortocoronary bypass].
    Fritz KW; Eglins P; Höge B; Hehrlein FW; Lüllwitz E; Kirchner E
    Intensivmed Prax; 1982 Jun; 5():27-38. PubMed ID: 6984020
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of isosorbide dinitrate on the blood circulation system in patients with ischemic heart disease].
    Gaponenko VA; Santova RA; Chilikina ON; Akhmetova MG; Moskalenko NP; Glezer GA
    Ross Med Zh; 1992; (4):45-7. PubMed ID: 1521022
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of long-term molsidomine treatment versus isosorbide dinitrate and placebo on exercise tolerance in stable angina.
    Romano M; de Caprio L; Meccariello P; Cuomo S; Baldini F; D'Ascia C; Steinberg G; Chiariello M
    Int J Clin Pharmacol Ther Toxicol; 1984 May; 22(5):246-9. PubMed ID: 6430811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodynamic effects of oral and sublingual forms of isosorbide dinitrate in patients with acute coronary insufficiency.
    Poliner LR; Ritter W; Wohl AJ; Nixon JV; Willerson JT
    Tex Med; 1977 Feb; 73(2):53-8. PubMed ID: 841487
    [No Abstract]   [Full Text] [Related]  

  • 11. [Long-term tolerance and effect of isosorbide-5-mononitrate in comparison to isosorbide dinitrate (ISDN retard) in patients with coronary disease].
    Smolarz A; Seeliger S; Glocke M
    Med Welt; 1981 Apr; 32(14A):548-53. PubMed ID: 6787385
    [No Abstract]   [Full Text] [Related]  

  • 12. Hemodynamic response to molsidomine in patients with ischemic cardiomyopathy tolerant to isosorbide dinitrate.
    Unger P; Leone A; Staroukine M; Degré S; Berkenboom G
    J Cardiovasc Pharmacol; 1991 Dec; 18(6):888-94. PubMed ID: 1725903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hemodynamic effects of isosorbide-5-mononitrate in ischemic cardiopathy].
    Russo G; Tolaro S; Monaco O; Greco G; Grassi R; Monaco A; Calvi V; Felis S; Tamburino C; Giuffrida G
    Cardiologia; 1988 Mar; 33(3):291-5. PubMed ID: 3401892
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of nitrosorbide on the hemodynamics under physical loading in patients with ischemic heart disease].
    Kupchinskaia EG; Stadniuk LA; Tkhor NV; Vysotskaia ZhM; Golub' NS
    Vrach Delo; 1986 Nov; (11):66-8. PubMed ID: 3825049
    [No Abstract]   [Full Text] [Related]  

  • 15. [Ergometric and clinical results of treating coronary disease with isosorbide dinitrate and verapamil].
    Pozenel H
    Med Welt; 1981 Jun; 32(24):988-92. PubMed ID: 7253907
    [No Abstract]   [Full Text] [Related]  

  • 16. The haemodynamic and anti-ischaemic effects of a single tablet of 80 mg isosorbide dinitrate in slow-release formulation and a review of nitrate tolerance.
    Silber S; Vogler AC; Krause KH; Theisen K
    Drugs; 1987; 33 Suppl 4():69-79. PubMed ID: 3622317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term treatment of patients with coronary heart disease using isosorbide dinitrate, nifedipine and molsidomine.
    Jansen W; Tauchert M; Osterspey A; Hombach V; Fuchs M; Hilger HH
    Z Kardiol; 1983; 72 Suppl 3():203-10. PubMed ID: 6689389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of isosorbide-5-mononitrate (IS-5-MN) on left ventricular hemodynamics].
    Mehmel HC; Ruffmann K; Schwarz F; Manthey J; Kübler W
    Med Welt; 1981 Apr; 32(14A):527-9. PubMed ID: 7242314
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hemodynamic changes at rest and during stress following isosorbide-5-mononitrate therapy in patients with coronary disease].
    Isbary J; Doering W; Wauer B; Greding H; König E
    Med Welt; 1981 Apr; 32(14A):530-4. PubMed ID: 7242315
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparative ergometric tests in coronary disease patients under betasympathicolysis using Betadrenol and Isoket].
    Raff U; Jeschke D
    Med Welt; 1977 Sep; 28(38):1518-21. PubMed ID: 20547
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.